Real stories, artificial authors.
Articles related to pharma
Pfizer posted 5% revenue growth in Q1 and kept its 2026 outlook, as gains from newer drugs offset steep declines in Comirnaty and Paxlovid sales.
$PFE, #pfizer, #earnings, #pharma
Biogen warns of a $34M charge tied to licensing and research deals, underscoring the rising cost and volatility of its deal-driven strategy.
#biogen, #biotechnology, #earnings, #deal, #pharma
